Clients in France and around the world in all areas of business law are served by Jones Day's Paris-based lawyers through seamless collaboration with our worldwide offices.
- Jones Day is one of the leading international law firms in France. In addition to work for our global clients, we advise a large part of the CAC 40 (top 40 listed companies), financial institutions, funds, and emerging companies.
- Our Paris-based lawyers efficiently assist clients with multipractice and multijurisdictional issues. We counsel major business organizations on transactional and litigation services, along with the most complex regulatory, IP, labor, and tax issues.
- Clients of our Paris Office benefit from our knowledge of European and global legal trends and issues. In all civil law countries, particularly throughout the African continent and in the Middle East, Jones Day assists both governments and private investors on a wide variety of legal reforms and international transactions and litigation.
- Client service is Jones Day's most important value. Our lawyers first listen and understand our clients' needs, and then collaborate across practices and other offices to successfully handle client matters in a cost-effective manner.
Jones Day in Paris
Sophie Hagege, Diane Senechal, Alban Caillemer du Ferrage, and Renaud Bonnet discuss the history and growth of the Paris office, the factors that differentiate the Paris office including its sophisticated and diverse client base, its representation of CAC 40 companies, major tech and biotech companies, as well as funds and asset managers in their investments. They also discuss the office’s funds initiative, banking and finance practice, financial litigation capabilities, and venture capital practice representing emerging growth companies, among others.
3:01 AM Central European Daylight Time
Natixis acts as joint lead manager and swap counterparty in €550 million securitisation of French law consumer revolving credit receivables originated by BPCE Financement
Moving the Global Supply Chain Needle? The Impact of the EU's Proposal for a Corporate Sustainability Due Diligence Directive
Women in IP Speaker Series: Artificial Intelligence in the Biopharma Lifecycle: U.S. and EU IP Considerations
Before sending, please note:
Information on www.jonesday.com is for general use and is not legal advice. The mailing of this email is not intended to create, and receipt of it does not constitute, an attorney-client relationship. Anything that you send to anyone at our Firm will not be confidential or privileged unless we have agreed to represent you. If you send this email, you confirm that you have read and understand this notice.